Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GANA R&D is a South Korean biotechnology company specializing in the development and manufacture of innovative aesthetic and regenerative medicine products. The company is best known for its advanced injectable fillers, particularly its Poly-L-lactic acid (PLLA) based products like Gana Fill, which stimulate endogenous collagen production for long-lasting tissue restoration. Beyond dermal fillers, GANA R&D produces a range of medical devices and cosmeceuticals focused on dermatology and plastic surgery. Their portfolio includes hyaluronic acid fillers, thread lifting solutions, and specialized treatments for hair loss and skin revitalization. The company maintains a strong global presence, exporting its proprietary aesthetic solutions to numerous international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GANA R&D.